TY  - JOUR
AU  - Blasco, Lucia
AU  - Ambroa, Anton
AU  - Lopez, Maria
AU  - Fernandez-Garcia, Laura
AU  - Bleriot, Ines
AU  - Trastoy, Rocio
AU  - Ramos-Vivas, Jose
AU  - Coenye, Tom
AU  - Fernandez-Cuenca, Felipe
AU  - Vila, Jordi
AU  - Martinez-Martinez, Luis
AU  - Rodriguez-Baño, Jesus
AU  - Pascual, Alvaro
AU  - Cisneros, Jose Miguel
AU  - Pachon, Jeronimo
AU  - Bou, German
AU  - Tomas, Maria
PY  - 2019
DO  - 10.3390/microorganisms7110556
SN  - 2076-2607
UR  - http://hdl.handle.net/10668/14690
T2  - Microorganisms
AB  - Phage therapy is an abandoned antimicrobial therapy that has been resumed in recent years. In this study, we mutated a lysogenic phage from cinetobacter baumannii into a lytic phage (Ab105-2phi∆CI) that displayed antimicrobial activity against A....
LA  - en
PB  - MDPI
KW  - Acinetobacter baumannii
KW  - Antibiotic-phage synergy
KW  - Multiresistant
KW  - Mutant lytic phage
KW  - Phage therapy
KW  - Meropenem
KW  - Acinetobacter baumannii
KW  - Databases, nucleic acid
KW  - Phage therapy
KW  - Anti-bacterial agents
KW  - Imipenem
KW  - Bacteriophages
KW  - Meropenem
KW  - Acinetobacter baumannii
KW  - Databases, nucleic acid
KW  - Phage therapy
KW  - Anti-bacterial agents
KW  - Imipenem
TI  - Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumannii.
TY  - Research article
VL  - 7
ER  -